Tuberculosis (TB) is a chronic infectious disease caused by the bacterium Mycobacterium tuberculosis. Pulmonary TB is the most common form, primarily affecting the lungs. TB is transmitted through the inhalation of respiratory droplets containing M. tuberculosis. The disease can manifest as active TB, latent TB infection, or extrapulmonary TB. Symptoms of active pulmonary TB include persistent cough, chest pain, weight loss, and hemoptysis. Diagnosis involves clinical evaluation, imaging studies, and laboratory tests, such as sputum culture and molecular assays. Treatment typically involves a combination of antibiotics, such as isoniazid, rifampin, and ethambutol, over an extended duration. Preventive measures for pulmonary infections like TB include vaccination with the Bacillus Calmette-Guérin (BCG) vaccine, particularly in regions with high TB prevalence. Public health efforts also focus on early detection, contact tracing, and directly observed therapy to control the spread of TB. Ongoing research explores new diagnostic tools, treatment regimens, and strategies for TB control, especially in the context of emerging drug-resistant strains.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain